![]() |
|
|
Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111
3To whom correspondence should be addressed. E-mail: >blumberg@hnrc.tufts.edu" locator-type="email">locator-type="email">blumberg@hnrc.tufts.edu locator="" locator-type="email">
Elevated homocysteine has been identified as an independent risk factor
for cardiovascular and cerebrovascular disease. Although multivitamin
use has been associated with low plasma homocysteine concentrations in
several observational studies, no clinical trials have been conducted
using multivitamin/mineral supplements to lower homocysteine. We
determined whether a multivitamin/mineral supplement formulated at
about 100% Daily Value will further lower homocysteine concentration
and improve B-vitamin status in healthy older adults already
consuming a diet fortified with folic acid. In this randomized,
double-blind, placebo-controlled trial, 80 free-living men and
women aged 5087 y with total plasma homocysteine concentrations of
8 µmol/L received either a multivitamin/mineral supplement or
placebo for 56 d while consuming their usual diet. After the 8-wk
treatment, subjects taking the supplement had significantly higher
B-vitamin status and lower homocysteine concentration than controls
(P < 0.01). Plasma folate, pyridoxal phosphate
(PLP) and vitamin B-12 concentrations were increased 41.6, 36.5 and
13.8%, respectively, in the supplemented group, whereas no
changes were observed in the placebo group. The mean homocysteine
concentration decreased 9.6% in the supplemented group (P
< 0.001) and was unaffected in the placebo group. There were no
significant changes in dietary intake during the intervention.
Multivitamin/mineral supplementation can improve B-vitamin status
and reduce plasma homocysteine concentration in older adults already
consuming a folate-fortified diet.
KEY WORDS: homocysteine multivitamin aging humans folic acid supplements
This article has been cited by other articles:
![]() |
D. L. McKay, J. M. Berkowitz, J. B. Blumberg, and J. P. Goldberg Communicating Cardiovascular Disease Risk Due to Elevated Homocysteine Levels: Using the EPPM to Develop Print Materials Health Educ Behav, June 1, 2004; 31(3): 355 - 371. [Abstract] [PDF] |
||||
![]() |
C. Holmquist, S. Larsson, A. Wolk, and U. de Faire Multivitamin Supplements Are Inversely Associated with Risk of Myocardial Infarction in Men and Women--Stockholm Heart Epidemiology Program (SHEEP) J. Nutr., August 1, 2003; 133(8): 2650 - 2654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lokk News and Views on Folate and Elderly Persons J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M354 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Haulrik, S. Toubro, J. Dyerberg, S. Stender, A. R Skov, and A. Astrup Effect of protein and methionine intakes on plasma homocysteine concentrations: a 6-mo randomized controlled trial in overweight subjects Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1202 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G Ronnenberg, M. B Goldman, D. Chen, I. W Aitken, W. C Willett, J. Selhub, and X. Xu Preconception homocysteine and B vitamin status and birth outcomes in Chinese women Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1385 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Rader Folic Acid Fortification, Folate Status and Plasma Homocysteine J. Nutr., August 1, 2002; 132(8): 2466S - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Kwan, O. I. Bermudez, and K. L. Tucker Low Vitamin B-12 Intake and Status Are More Prevalent in Hispanic Older Adults of Caribbean Origin Than in Neighborhood-Matched Non-Hispanic Whites J. Nutr., July 1, 2002; 132(7): 2059 - 2064. [Abstract] [Full Text] [PDF] |
||||